COOPERMAN BARNABAS MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $6.1M
- Transactions
- 946
- Companies
- 40
- Average per transaction
- $6,494
Who reported the payments
| Gilead | $2,013,849 |
| Novartis | $1,536,151 |
| Merck | $690,473 |
| Genentech, Inc. | $379,936 |
| Biogen | $306,223 |
| CSL Behring | $212,269 |
| Astrazeneca UK Limited | $189,026 |
| Stryker | $77,606 |
| F. Hoffmann-la Roche AG | $69,405 |
| Ipsen Biopharmaceuticals, Inc | $56,550 |
| Barco, Inc. | $49,630 |
| Linde Gas & Equipment Inc. | $47,520 |
| Regeneron | $46,605 |
| Astellas Pharma Global Development | $46,302 |
| Macrogenics, Inc. | $43,696 |
| AbbVie | $38,831 |
| Boston Scientific | $37,906 |
| Abbott | $37,684 |
| Medtronic | $35,990 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33,734 |
| E.r. Squibb & Sons, L.L.C. | $30,016 |
| Pfizer | $19,707 |
| Shionogi Inc | $13,000 |
| Siemens Medical Solutions USA, Inc. | $10,630 |
| Sanofi-aventis U.S. LLC | $10,500 |
| Mallinckrodt Hospital Products Inc. | $10,086 |
| Immedica Pharma US, Inc. | $9,375 |
| Johnson & Johnson | $8,925 |
| Intuitive Surgical | $6,850 |
| AstraZeneca | $6,500 |
| W. L. Gore & Associates, Inc. | $4,952 |
| Shire North American Group Inc | $4,764 |
| Mentor Worldwide LLC | $4,500 |
| Zimmer Biomet | $4,142 |
| Davol Inc. | $4,122 |
| Veloxis Pharmaceuticals, Inc. | $4,000 |
| Aesculap Implant Systems, LLC | $3,196 |
| Regeneron Healthcare Solutions, Inc. | $3,100 |
| Linvatec Corporation | $2,979 |
| Edwards Lifesciences | $2,740 |